Chul‐Ho Jeong

2.9k total citations
69 papers, 2.4k citations indexed

About

Chul‐Ho Jeong is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Chul‐Ho Jeong has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Chul‐Ho Jeong's work include Neurotransmitter Receptor Influence on Behavior (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Chul‐Ho Jeong is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (10 papers), Cancer, Hypoxia, and Metabolism (9 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Chul‐Ho Jeong collaborates with scholars based in South Korea, United States and Japan. Chul‐Ho Jeong's co-authors include Won‐Jun Jang, Kyu‐Won Kim, Sooyeun Lee, Joo‐Won Jeong, Sang Hoon Joo, Nirmala Tilija Pun, Byoungduck Park, Young Ho Seo, Ann M. Bode and Jae‐Sun Choi and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Scientific Reports.

In The Last Decade

Chul‐Ho Jeong

69 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chul‐Ho Jeong South Korea 26 1.2k 502 323 194 191 69 2.4k
Yuanyuan Wu China 27 1.1k 0.9× 340 0.7× 299 0.9× 197 1.0× 155 0.8× 116 2.2k
Zhou‐Yan Bian China 31 1.1k 0.9× 258 0.5× 259 0.8× 189 1.0× 152 0.8× 63 2.2k
Acharan S. Narula India 27 1.6k 1.3× 413 0.8× 344 1.1× 177 0.9× 226 1.2× 96 3.4k
Dandan Wu China 19 1.2k 1.0× 427 0.9× 175 0.5× 184 0.9× 108 0.6× 33 2.3k
Jie Su China 26 1.1k 0.9× 246 0.5× 292 0.9× 191 1.0× 134 0.7× 133 2.1k
Xuejun Jin China 34 1.6k 1.3× 630 1.3× 374 1.2× 200 1.0× 282 1.5× 91 3.0k
Mükerrem Betül Yerer Türkiye 20 1.1k 0.9× 293 0.6× 246 0.8× 129 0.7× 121 0.6× 79 2.5k
Keon Wook Kang South Korea 30 1.7k 1.4× 295 0.6× 335 1.0× 292 1.5× 226 1.2× 87 2.7k
Byoungduck Park South Korea 23 1.2k 1.0× 305 0.6× 321 1.0× 127 0.7× 203 1.1× 57 2.4k
Mi‐Kyoung Kwak South Korea 34 2.5k 2.0× 601 1.2× 376 1.2× 236 1.2× 149 0.8× 71 3.8k

Countries citing papers authored by Chul‐Ho Jeong

Since Specialization
Citations

This map shows the geographic impact of Chul‐Ho Jeong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chul‐Ho Jeong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chul‐Ho Jeong more than expected).

Fields of papers citing papers by Chul‐Ho Jeong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chul‐Ho Jeong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chul‐Ho Jeong. The network helps show where Chul‐Ho Jeong may publish in the future.

Co-authorship network of co-authors of Chul‐Ho Jeong

This figure shows the co-authorship network connecting the top 25 collaborators of Chul‐Ho Jeong. A scholar is included among the top collaborators of Chul‐Ho Jeong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chul‐Ho Jeong. Chul‐Ho Jeong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Park, Seongjun, Naeun Lee, & Chul‐Ho Jeong. (2023). ACY-241, a histone deacetylase 6 inhibitor, suppresses the epithelial–mesenchymal transition in lung cancer cells by downregulating hypoxia-inducible factor-1 alpha. Korean Journal of Physiology and Pharmacology. 28(1). 83–91. 2 indexed citations
3.
Song, Sang-Hoon, Won‐Jun Jang, Eun Young Jang, et al.. (2022). Striatal miR-183-5p inhibits methamphetamine-induced locomotion by regulating glucocorticoid receptor signaling. Frontiers in Pharmacology. 13. 997701–997701. 4 indexed citations
4.
Pun, Nirmala Tilija & Chul‐Ho Jeong. (2021). Statin as a Potential Chemotherapeutic Agent: Current Updates as a Monotherapy, Combination Therapy, and Treatment for Anti-Cancer Drug Resistance. Pharmaceuticals. 14(5). 470–470. 52 indexed citations
5.
Pun, Nirmala Tilija, Won‐Jun Jang, & Chul‐Ho Jeong. (2020). Role of autophagy in regulation of cancer cell death/apoptosis during anti-cancer therapy: focus on autophagy flux blockade. Archives of Pharmacal Research. 43(5). 475–488. 43 indexed citations
6.
Jang, Won‐Jun, Byoungduck Park, Ji Hae Seo, et al.. (2019). Hair Metabolomics in Animal Studies and Clinical Settings. Molecules. 24(12). 2195–2195. 32 indexed citations
7.
Sharma, Chiranjeev, Byoungduck Park, Sooyeun Lee, et al.. (2019). Development of Thiazolidinedione-Based HDAC6 Inhibitors to Overcome Methamphetamine Addiction. International Journal of Molecular Sciences. 20(24). 6213–6213. 14 indexed citations
8.
Song, Sang-Hoon, Won‐Jun Jang, Jihye Hwang, et al.. (2018). Transcriptome profiling of whisker follicles in methamphetamine self-administered rats. Scientific Reports. 8(1). 11420–11420. 6 indexed citations
9.
Lee, Jangho, Joon Park, Young Ho Kim, et al.. (2018). Syringic acid prevents skin carcinogenesis via regulation of NoX and EGFR signaling. Biochemical Pharmacology. 154. 435–445. 52 indexed citations
10.
Kundu, Juthika, Do-Hee Kim, In Gyeong Chae, et al.. (2018). Silicon dioxide nanoparticles induce COX-2 expression through activation of STAT3 signaling pathway in HaCaT cells. Toxicology in Vitro. 52. 235–242. 18 indexed citations
11.
Jeong, Chul‐Ho, et al.. (2017). Development of a linear dual column HPLC–MS/MS method and clinical genetic evaluation for tramadol and its phase I and II metabolites in oral fluid. Archives of Pharmacal Research. 41(3). 288–298. 12 indexed citations
12.
Jang, Won‐Jun, Sang-Hoon Song, Naeun Lee, et al.. (2017). Multi-omics analysis reveals that ornithine decarboxylase contributes to erlotinib resistance in pancreatic cancer cells. Oncotarget. 8(54). 92727–92742. 19 indexed citations
13.
Bae, Jung‐Woo, et al.. (2016). Drug-Drug Interaction of Paroxetine and Atomoxetine in Different CYP2D6 Genotypes. Clinical Therapeutics. 38(10). e23–e23. 2 indexed citations
14.
Jang, Won‐Jun, Byoungduck Park, Gil‐Saeng Jeong, Soon‐Sun Hong, & Chul‐Ho Jeong. (2014). SB365, Pulsatilla saponin D, suppresses the growth of gefitinib-resistant NSCLC cells with Met amplification. Oncology Reports. 32(6). 2612–2618. 10 indexed citations
15.
Im, Nam-Kyung, Won‐Jun Jang, Chul‐Ho Jeong, & Gil‐Saeng Jeong. (2014). Delphinidin Suppresses PMA-Induced MMP-9 Expression by Blocking the NF-κB Activation Through MAPK Signaling Pathways in MCF-7 Human Breast Carcinoma Cells. Journal of Medicinal Food. 17(8). 855–861. 47 indexed citations
16.
Oi, Naomi, Chul‐Ho Jeong, Janos Nadas, et al.. (2010). Resveratrol, a Red Wine Polyphenol, Suppresses Pancreatic Cancer by Inhibiting Leukotriene A4 Hydrolase. Cancer Research. 70(23). 9755–9764. 79 indexed citations
17.
Choi, Jae‐Sun & Chul‐Ho Jeong. (2010). Anti-angiogenic Effect of Linalool. Journal of Cancer Prevention. 15(2). 133–137. 1 indexed citations
18.
Jeong, Chul‐Ho, Ann M. Bode, Angelo Pugliese, et al.. (2009). [6]-Gingerol Suppresses Colon Cancer Growth by Targeting Leukotriene A4 Hydrolase. Cancer Research. 69(13). 5584–5591. 149 indexed citations
19.
Jeong, Chul‐Ho, Sehee Kim, Moon‐Kyoung Bae, et al.. (2002). Regulation of Egr-1 by association with the proteasome component C8. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1592(2). 163–167. 38 indexed citations
20.
Lee, You Mie, Chul‐Ho Jeong, Sunyoung Koo, et al.. (2001). Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: A possible signal for vessel development. Developmental Dynamics. 220(2). 175–186. 242 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026